Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia

Venus Remedies on Monday said it has received approval to market a drug, which prevents blood clots, in Saudi Arabia. The company has received the marketing approval for Enoxaparin in pre-filled syringes, the drug firm said in a statement on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Rjwz1Qo
via IFTTT